Balance Sheet Insights: Reviva Pharmaceuticals Holdings Inc (RVPH)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.

In the latest session, Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) closed at $0.53 up 2.81% from its previous closing price of $0.52. In other words, the price has increased by $2.81 from its previous closing price. On the day, 2.43 million shares were traded. RVPH stock price reached its highest trading level at $0.5487 during the session, while it also had its lowest trading level at $0.5101.

Ratios:

For a deeper understanding of Reviva Pharmaceuticals Holdings Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.90 and its Current Ratio is at 0.90.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, ROTH MKM on September 20, 2023, initiated with a Buy rating and assigned the stock a target price of $12.

On June 08, 2023, The Benchmark Company started tracking the stock assigning a Speculative Buy rating and target price of $17.

On January 24, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $10.H.C. Wainwright initiated its Buy rating on January 24, 2022, with a $10 target price.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RVPH now has a Market Capitalization of 36300324 and an Enterprise Value of 25057008.

Stock Price History:

The Beta on a monthly basis for RVPH is -0.04, which has changed by -0.37647057 over the last 52 weeks, in comparison to a change of 0.14064062 over the same period for the S&P500. Over the past 52 weeks, RVPH has reached a high of $4.28, while it has fallen to a 52-week low of $0.30. The 50-Day Moving Average of the stock is 5.48%, while the 200-Day Moving Average is calculated to be -51.59%.

Shares Statistics:

For the past three months, RVPH has traded an average of 2.44M shares per day and 3108950 over the past ten days. A total of 68.00M shares are outstanding, with a floating share count of 60.81M. Insiders hold about 10.59% of the company’s shares, while institutions hold 21.25% stake in the company. Shares short for RVPH as of 1753920000 were 11951705 with a Short Ratio of 4.90, compared to 1751241600 on 3578734. Therefore, it implies a Short% of Shares Outstanding of 11951705 and a Short% of Float of 19.399999.

Earnings Estimates

The stock of Reviva Pharmaceuticals Holdings Inc (RVPH) is currently drawing attention from 3.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is -$0.11, with high estimates of -$0.1 and low estimates of -$0.12.

Analysts are recommending an EPS of between -$0.45 and -$0.47 for the fiscal current year, implying an average EPS of -$0.46. EPS for the following year is -$0.48, with 5.0 analysts recommending between -$0.3 and -$0.91.

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.